Clinical trial on the absorption of triglyceride form of DHA by intake conditions (Pilot Study)-A randomized open label crossover study
- Conditions
- Healthy adults
- Registration Number
- JPRN-UMIN000041670
- Lead Sponsor
- FANCL Corporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Not provided
1. Patient with dyslipidaemia. 2. Subjects with severe liver diseases, digestive organ diseases, kidney diseases and heart diseases. 3. Subjects who have history of surgical resection of the gastrointestinal tract (except for appendectomy). 4. Subjects who have various symptoms of indigestion (diarrhea, stomach feels upset etc.). 5. Subjects who are bleeding at present or danger of bleeding (serious injuries and operations, etc.) 6. Can't stop to take a supplement or medicine including DHA, EPA during the study period. 7. Difficulty in collecting blood. 8. Smoker 9. Subjects who are planned to participate in other clinical study. 10. Subjects who intend to become pregnant or lactating. 11. Subjects who are judged as unsuitable for the study by the investigator for other reason
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method